Skip to main content
Log in

Adalimumab

Tuberculosis and ineffectiveness

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Yu J, et al. Effectiveness and safety of adalimumab in patients with intestinal Behcet's disease: a real-world prospective observational study in South Korea. BMC Gastroenterology 23: Jan 2023. Available from: URL: https://dx.doi.org/10.1186/s12876-023-03090-x

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 2002, 21 (2024). https://doi.org/10.1007/s40278-024-55398-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-55398-9

Navigation